The potential predictive value of PD-L1/PD-1 expression for the efficacy of immunotherapy in salivary gland tumors is not yet understood, and the majority of publications related to ACC focus on PD-L1 and PD-1 expression in head and neck tumors [23]. The gene discussed is PDCD1; the disease is tumor of salivary gland.